[When to consider type I interferonopathy in adulthood?]

doi:10.1016/j.revmed.2021.11.003

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

[When to consider type I interferonopathy in adulthood?]

La Revue de medecine interne - 1 Jun 2022

David C, Frémond M-L

Abstract excerpt

Type I interferonopathies (IP1) are a heterogeneous group of Mendelian diseases characterized by overactivation of the type I interferon (IFN) pathway. They are caused by monogenic (rarely digenic) mutations of proteins involved in this key pathway of innate immunity. IP1 transmission can be dominant, recessive or X-linked and penetrance differs from one IP1 to another. The clinical spectrum is broad and mainly...

Topics

Adult
Autoimmune Diseases
Calcinosis
Humans
Interferon Type I
Mutation

Source

Open in PubMed

Identifiers

PMID: 35177256
DOI: 10.1016/j.revmed.2021.11.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics